Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMERICAN INTERNATIONAL GROUP, INC.AIG · Entity 3083 | Director | April 01, 2019 | April 02, 2019 |
| Avaya Holdings Corp.AVYA · Entity 117306 | Director | March 15, 2018 | March 15, 2018 |
| IQVIA HOLDINGS INC.IQV · Entity 3058 | Director | May 11, 2022 | May 13, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMERICAN INTERNATIONAL GROUP, INC.
Report date April 01, 2019 · Filed April 02, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred Stock UnitSEC Table II · derivative / convertible security | Direct | 19,537 |
Reported balance
After 2019-04-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2019-04-01 · Grant · Acquired 140 · Balance 19,537 F1: Dividend equivalent in the form of deferred stock units with respect to deferred stock units previously awarded under the American International Group, Inc. ("AIG") 2010 Stock Incentive Plan (the "2010 Plan") and the AIG 2013 Omnibus Incentive Plan (the "2013 Plan"). Subject to the terms of the 2010 Plan and the 2013 Plan, respectively, and the related award agreement, shares of AIG Common Stock underlying the deferred stock units will be deliverable, without any cash consideration or conditions, on the last trading day of the month in which the director ceases to be a director of AIG. F2: Reflects deferred stock units previously granted pursuant to the 2010 Plan and the 2013 Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Dividend equivalent in the form of deferred stock units with respect to deferred stock units previously awarded under the American International Group, Inc. ("AIG") 2010 Stock Incentive Plan (the "2010 Plan") and the AIG 2013 Omnibus Incentive Plan (the "2013 Plan"). Subject to the terms of the 2010 Plan and the 2013 Plan, respectively, and the related award agreement, shares of AIG Common Stock underlying the deferred stock units will be deliverable, without any cash consideration or conditions, on the last trading day of the month in which the director ceases to be a director of AIG.
F2: Reflects deferred stock units previously granted pursuant to the 2010 Plan and the 2013 Plan.
Avaya Holdings Corp.
Report date March 15, 2018 · Filed March 15, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.01 per shareSEC Table I · non-derivative | Direct | 3,211 |
Reported balance
After 2018-03-15 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2018-03-15 · Exercise / conversion · Acquired 3,211 · Balance 3,211 F1: Represents awards of Restricted Stock Units granted on January 23, 2018, pursuant to the Avaya Holdings Corp. 2017 Equity Incentive Plan (the "EIP"), that vest on March 15, 2018. Each Restricted Stock Unit represents a contingent right to receive, at vesting, one share of common stock of Avaya Holdings Corp. Distribution of this common stock will be deferred until the earliest to occur of: (x) December 15, 2020, (y) the recipient's separation of service from the registrant and (z) a "change in control" of the registrant, as defined in the EIP. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 9,636 |
Reported balance
After 2018-03-15 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2018-03-15 · Exercise / conversion · Disposed 3,211 · Balance 9,636 F1: Represents awards of Restricted Stock Units granted on January 23, 2018, pursuant to the Avaya Holdings Corp. 2017 Equity Incentive Plan (the "EIP"), that vest on March 15, 2018. Each Restricted Stock Unit represents a contingent right to receive, at vesting, one share of common stock of Avaya Holdings Corp. Distribution of this common stock will be deferred until the earliest to occur of: (x) December 15, 2020, (y) the recipient's separation of service from the registrant and (z) a "change in control" of the registrant, as defined in the EIP. F2: Represents Restricted Stock Units that have vested as the Common Stock set forth in Table I. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents awards of Restricted Stock Units granted on January 23, 2018, pursuant to the Avaya Holdings Corp. 2017 Equity Incentive Plan (the "EIP"), that vest on March 15, 2018. Each Restricted Stock Unit represents a contingent right to receive, at vesting, one share of common stock of Avaya Holdings Corp. Distribution of this common stock will be deferred until the earliest to occur of: (x) December 15, 2020, (y) the recipient's separation of service from the registrant and (z) a "change in control" of the registrant, as defined in the EIP.
F2: Represents Restricted Stock Units that have vested as the Common Stock set forth in Table I.
IQVIA HOLDINGS INC.
Report date May 11, 2022 · Filed May 13, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 13,533 |
Reported balance
After 2022-05-11 transaction · row 1
1 source rowRow 1 · 2022-05-11 · Grant · Acquired 995 · Balance 13,533 F1: Shares acquired from award of IQVIA Holdings Inc. common stock for Non-Employee Directors that are fully vested upon grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares acquired from award of IQVIA Holdings Inc. common stock for Non-Employee Directors that are fully vested upon grant.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
IMS Health Holdings, Inc.
Report date October 03, 2016 · Filed October 03, 2016
Section 16 reporting ended · disclosed 2016-10-03. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2016-10-03 transaction · row 1
1 source rowRow 1 · 2016-10-03 · Disposition to issuer · Disposed 142,840 · Balance 0 F1: On May 3, 2016, the issuer and Quintiles Transnational Holdings, Inc. ("Quintiles") entered into an Agreement and Plan of Merger pursuant to which on October 3, 2016 the issuer merged with and into Quintiles (the "merger"), the separate existence of the issuer ceased and Quintiles will continue as the surviving corporation, operating under the name Quintiles IMS Holdings, Inc. F2: Disposed of pursuant to merger agreement in exchange for 54,849 shares of Quintiles IMS Holdings, Inc. stock having a market value of $81.06 per share at the effective time of the merger. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $10.00 · Expires 2020-07-20 | Direct | 0 |
Reported balance
After 2016-10-03 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2016-10-03 · Disposition to issuer · Disposed 20,000 · Balance 0 F3: This option was assumed by Quintiles in the merger and replaced with an option to purchase 7,680 shares of Quintiles IMS Holdings, Inc. common stock at a price of $26.05 per share. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $5.80 · Expires 2020-07-20 | Direct | 0 |
Reported balance
After 2016-10-03 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2016-10-03 · Disposition to issuer · Disposed 10,000 · Balance 0 F4: This option was assumed by Quintiles in the merger and replaced with an option to purchase 3,840 shares of Quintiles IMS Holdings, Inc. common stock at a price of $15.11 per share. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.20 · Expires 2020-07-20 | Direct | 0 |
Reported balance
After 2016-10-03 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2016-10-03 · Disposition to issuer · Disposed 20,000 · Balance 0 F5: This option was assumed by Quintiles in the merger and replaced with an option to purchase 7,680 shares of Quintiles IMS Holdings, Inc. common stock at a price of $8.34 per share. |
Filing footnotes · ownership attribution and instrument terms
F1: On May 3, 2016, the issuer and Quintiles Transnational Holdings, Inc. ("Quintiles") entered into an Agreement and Plan of Merger pursuant to which on October 3, 2016 the issuer merged with and into Quintiles (the "merger"), the separate existence of the issuer ceased and Quintiles will continue as the surviving corporation, operating under the name Quintiles IMS Holdings, Inc.
F2: Disposed of pursuant to merger agreement in exchange for 54,849 shares of Quintiles IMS Holdings, Inc. stock having a market value of $81.06 per share at the effective time of the merger.
F3: This option was assumed by Quintiles in the merger and replaced with an option to purchase 7,680 shares of Quintiles IMS Holdings, Inc. common stock at a price of $26.05 per share.
F4: This option was assumed by Quintiles in the merger and replaced with an option to purchase 3,840 shares of Quintiles IMS Holdings, Inc. common stock at a price of $15.11 per share.
F5: This option was assumed by Quintiles in the merger and replaced with an option to purchase 7,680 shares of Quintiles IMS Holdings, Inc. common stock at a price of $8.34 per share.
TENET HEALTHCARE CORP
Report date September 30, 2022 · Filed October 04, 2022
Section 16 reporting ended · disclosed 2022-10-04. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 440,235 |
Reported balance
After 2022-09-30 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2022-09-30 · Exercise / conversion · Acquired 32,702 · Balance 440,235 F1: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 26, 2020, and vest and settle in eleven equal quarterly installments. F2: Restricted stock units convert into common stock on a one-for-one basis. |
| Common StockSEC Table I · non-derivative | Direct | 427,366 |
Reported balance
After 2022-09-30 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2022-09-30 · Tax withholding · Disposed 12,869 · Balance 427,366 F3: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. |
| Common StockSEC Table I · non-derivative | Direct | 451,018 |
Reported balance
After 2022-09-30 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2022-09-30 · Exercise / conversion · Acquired 23,652 · Balance 451,018 F4: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 24, 2021, and vest and settle in eight equal quarterly installments. F2: Restricted stock units convert into common stock on a one-for-one basis. |
| Common StockSEC Table I · non-derivative | Direct | 441,710 |
Reported balance
After 2022-09-30 transaction · row 4
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 4 · 2022-09-30 · Tax withholding · Disposed 9,308 · Balance 441,710 F3: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. |
| Common StockSEC Table I · non-derivative | Direct | 446,593 |
Reported balance
After 2022-09-30 transaction · row 5
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 5 · 2022-09-30 · Exercise / conversion · Acquired 4,883 · Balance 446,593 F5: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 23, 2022, and vest and settle in eleven equal quarterly installments. F2: Restricted stock units convert into common stock on a one-for-one basis. |
| Common StockSEC Table I · non-derivative | Direct | 444,671 |
Reported balance
After 2022-09-30 transaction · row 6
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 6 · 2022-09-30 · Tax withholding · Disposed 1,922 · Balance 444,671 F3: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. |
| 2020 February Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 32,702 |
Reported balance
After 2022-09-30 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2022-09-30 · Exercise / conversion · Disposed 32,702 · Balance 32,702 F1: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 26, 2020, and vest and settle in eleven equal quarterly installments. |
| 2021 February Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 23,652 |
Reported balance
After 2022-09-30 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2022-09-30 · Exercise / conversion · Disposed 23,652 · Balance 23,652 F4: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 24, 2021, and vest and settle in eight equal quarterly installments. |
| 2022 February Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 43,950 |
Reported balance
After 2022-09-30 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2022-09-30 · Exercise / conversion · Disposed 4,883 · Balance 43,950 F5: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 23, 2022, and vest and settle in eleven equal quarterly installments. |
| Common StockSEC Table I · non-derivative | IndirectBy spouse | 15,000 |
Reported balance
Holding disclosure · report date 2022-09-30 · row 7
Holding and transaction disclosures are not merged.
1 source rowRow 7 · Balance 15,000 |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 26, 2020, and vest and settle in eleven equal quarterly installments.
F2: Restricted stock units convert into common stock on a one-for-one basis.
F3: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3.
F4: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 24, 2021, and vest and settle in eight equal quarterly installments.
F5: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 23, 2022, and vest and settle in eleven equal quarterly installments.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2022 Filed Oct 4, 2022 21:44 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversion2022 February Restricted Stock Units · Derivative | 4,883 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-052412 · doc4.xml · derivative · entry 10 Rittenmeyer Ronald A · CIK 0001210018 · Director · Former Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,950 Underlying: Common Stock · 4,883 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 23, 2022, and vest and settle in eleven equal quarterly installments. F5 · derivative.exercise_date: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 23, 2022, and vest and settle in eleven equal quarterly installments. F5 · derivative.expiration_date: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 23, 2022, and vest and settle in eleven equal quarterly installments. Read SEC document |
| September 30, 2022 Filed Oct 4, 2022 21:44 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversion2021 February Restricted Stock Units · Derivative | 23,652 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-052412 · doc4.xml · derivative · entry 9 Rittenmeyer Ronald A · CIK 0001210018 · Director · Former Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,652 Underlying: Common Stock · 23,652 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 24, 2021, and vest and settle in eight equal quarterly installments. F4 · derivative.exercise_date: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 24, 2021, and vest and settle in eight equal quarterly installments. F4 · derivative.expiration_date: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 24, 2021, and vest and settle in eight equal quarterly installments. Read SEC document |
| September 30, 2022 Filed Oct 4, 2022 21:44 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversion2020 February Restricted Stock Units · Derivative | 32,702 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-052412 · doc4.xml · derivative · entry 8 Rittenmeyer Ronald A · CIK 0001210018 · Director · Former Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,702 Underlying: Common Stock · 32,702 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 26, 2020, and vest and settle in eleven equal quarterly installments. F1 · derivative.exercise_date: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 26, 2020, and vest and settle in eleven equal quarterly installments. F1 · derivative.expiration_date: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 26, 2020, and vest and settle in eleven equal quarterly installments. Read SEC document |
| September 30, 2022 Filed Oct 4, 2022 21:44 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Tax withholdingCommon Stock | 1,922 | $51.58 | $99,136.76 |
DisclosureSEC source: 0001209191-22-052412 · doc4.xml · nonDerivative · entry 6 Rittenmeyer Ronald A · CIK 0001210018 · Director · Former Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 444,671 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document |
| September 30, 2022 Filed Oct 4, 2022 21:44 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionCommon Stock | 4,883 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-052412 · doc4.xml · nonDerivative · entry 5 Rittenmeyer Ronald A · CIK 0001210018 · Director · Former Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 446,593 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 23, 2022, and vest and settle in eleven equal quarterly installments. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| September 30, 2022 Filed Oct 4, 2022 21:44 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Tax withholdingCommon Stock | 9,308 | $51.58 | $480,106.64 |
DisclosureSEC source: 0001209191-22-052412 · doc4.xml · nonDerivative · entry 4 Rittenmeyer Ronald A · CIK 0001210018 · Director · Former Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 441,710 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document |
| September 30, 2022 Filed Oct 4, 2022 21:44 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionCommon Stock | 23,652 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-052412 · doc4.xml · nonDerivative · entry 3 Rittenmeyer Ronald A · CIK 0001210018 · Director · Former Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 451,018 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 24, 2021, and vest and settle in eight equal quarterly installments. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| September 30, 2022 Filed Oct 4, 2022 21:44 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Tax withholdingCommon Stock | 12,869 | $51.58 | $663,783.02 |
DisclosureSEC source: 0001209191-22-052412 · doc4.xml · nonDerivative · entry 2 Rittenmeyer Ronald A · CIK 0001210018 · Director · Former Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 427,366 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document |
| September 30, 2022 Filed Oct 4, 2022 21:44 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionCommon Stock | 32,702 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-052412 · doc4.xml · nonDerivative · entry 1 Rittenmeyer Ronald A · CIK 0001210018 · Director · Former Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 440,235 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 26, 2020, and vest and settle in eleven equal quarterly installments. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| June 30, 2022 Filed Jul 5, 2022 21:34 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversion2022 February Restricted Stock Units · Derivative | 4,883 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-040864 · doc4.xml · derivative · entry 10 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,833 Underlying: Common Stock · 4,883 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 23, 2022, and vest and settle in eleven equal quarterly installments. This footnote updates the vesting schedule that was incorrectly reported on the Form 4 filed by the reporting person on February 25, 2022. F5 · derivative.exercise_date: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 23, 2022, and vest and settle in eleven equal quarterly installments. This footnote updates the vesting schedule that was incorrectly reported on the Form 4 filed by the reporting person on February 25, 2022. F5 · derivative.expiration_date: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 23, 2022, and vest and settle in eleven equal quarterly installments. This footnote updates the vesting schedule that was incorrectly reported on the Form 4 filed by the reporting person on February 25, 2022. Read SEC document |
| June 30, 2022 Filed Jul 5, 2022 21:34 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversion2021 February Restricted Stock Units · Derivative | 23,652 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-040864 · doc4.xml · derivative · entry 9 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,304 Underlying: Common Stock · 23,652 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 24, 2021, and vest and settle in eight equal quarterly installments. F4 · derivative.exercise_date: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 24, 2021, and vest and settle in eight equal quarterly installments. F4 · derivative.expiration_date: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 24, 2021, and vest and settle in eight equal quarterly installments. Read SEC document |
| June 30, 2022 Filed Jul 5, 2022 21:34 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversion2020 February Restricted Stock Units · Derivative | 32,701 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-040864 · doc4.xml · derivative · entry 8 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,404 Underlying: Common Stock · 32,701 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 26, 2020, and vest and settle in eleven equal quarterly installments. F1 · derivative.exercise_date: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 26, 2020, and vest and settle in eleven equal quarterly installments. F1 · derivative.expiration_date: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 26, 2020, and vest and settle in eleven equal quarterly installments. Read SEC document |
| June 30, 2022 Filed Jul 5, 2022 21:34 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Tax withholdingCommon Stock | 1,922 | $52.56 | $101,020.32 |
DisclosureSEC source: 0001209191-22-040864 · doc4.xml · nonDerivative · entry 6 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 407,533 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document |
| June 30, 2022 Filed Jul 5, 2022 21:34 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionCommon Stock | 4,883 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-040864 · doc4.xml · nonDerivative · entry 5 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 409,455 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 23, 2022, and vest and settle in eleven equal quarterly installments. This footnote updates the vesting schedule that was incorrectly reported on the Form 4 filed by the reporting person on February 25, 2022. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| June 30, 2022 Filed Jul 5, 2022 21:34 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Tax withholdingCommon Stock | 9,308 | $52.56 | $489,228.48 |
DisclosureSEC source: 0001209191-22-040864 · doc4.xml · nonDerivative · entry 4 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 404,572 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document |
| June 30, 2022 Filed Jul 5, 2022 21:34 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionCommon Stock | 23,652 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-040864 · doc4.xml · nonDerivative · entry 3 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 413,880 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 24, 2021, and vest and settle in eight equal quarterly installments. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| June 30, 2022 Filed Jul 5, 2022 21:34 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Tax withholdingCommon Stock | 12,868 | $52.56 | $676,342.08 |
DisclosureSEC source: 0001209191-22-040864 · doc4.xml · nonDerivative · entry 2 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 390,228 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document |
| June 30, 2022 Filed Jul 5, 2022 21:34 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionCommon Stock | 32,701 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-040864 · doc4.xml · nonDerivative · entry 1 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 403,096 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 26, 2020, and vest and settle in eleven equal quarterly installments. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| May 11, 2022 Filed May 13, 2022 21:05 UTC | IQVIA HOLDINGS INC. IQV · Entity 3058 | GrantCommon Stock | 995 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-22-000076 · wf-form4_165247581647760.xml · nonDerivative · entry 1 Rittenmeyer Ronald A · CIK 0001210018 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,533 F1 · shares: Shares acquired from award of IQVIA Holdings Inc. common stock for Non-Employee Directors that are fully vested upon grant. Read SEC document |
| March 31, 2022 Filed Apr 1, 2022 20:52 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversion2021 February Restricted Stock Units · Derivative | 23,652 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-022015 · doc4.xml · derivative · entry 7 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,956 Underlying: Common Stock · 23,652 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 24, 2021, and vest and settle in eight equal quarterly installments. F4 · derivative.exercise_date: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 24, 2021, and vest and settle in eight equal quarterly installments. F4 · derivative.expiration_date: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 24, 2021, and vest and settle in eight equal quarterly installments. Read SEC document |
| March 31, 2022 Filed Apr 1, 2022 20:52 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversion2020 February Restricted Stock Units · Derivative | 32,701 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-022015 · doc4.xml · derivative · entry 6 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,105 Underlying: Common Stock · 32,701 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 26, 2020, and vest and settle in eleven equal quarterly installments. F1 · derivative.exercise_date: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 26, 2020, and vest and settle in eleven equal quarterly installments. F1 · derivative.expiration_date: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 26, 2020, and vest and settle in eleven equal quarterly installments. Read SEC document |
| March 31, 2022 Filed Apr 1, 2022 20:52 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Tax withholdingCommon Stock | 9,308 | $85.96 | $800,115.68 |
DisclosureSEC source: 0001209191-22-022015 · doc4.xml · nonDerivative · entry 4 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 370,395 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document |
| March 31, 2022 Filed Apr 1, 2022 20:52 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionCommon Stock | 23,652 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-022015 · doc4.xml · nonDerivative · entry 3 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 379,703 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 24, 2021, and vest and settle in eight equal quarterly installments. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| March 31, 2022 Filed Apr 1, 2022 20:52 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Tax withholdingCommon Stock | 12,868 | $85.96 | $1,106,133.28 |
DisclosureSEC source: 0001209191-22-022015 · doc4.xml · nonDerivative · entry 2 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 356,051 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document |
| March 31, 2022 Filed Apr 1, 2022 20:52 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionCommon Stock | 32,701 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-022015 · doc4.xml · nonDerivative · entry 1 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 368,919 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 26, 2020, and vest and settle in eleven equal quarterly installments. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| March 03, 2022 Filed Mar 4, 2022 21:31 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | SaleCommon Stock | 190,149 | $90.56 | $17,219,893.44 |
DisclosureSEC source: 0001209191-22-016269 · doc4.xml · nonDerivative · entry 2 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 336,218 F2 · price: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $90.00 to $90.96. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 21:31 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | SaleCommon Stock | 59,851 | $90.12 | $5,393,772.12 |
DisclosureSEC source: 0001209191-22-016269 · doc4.xml · nonDerivative · entry 1 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 526,367 F1 · price: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $90.00 to $90.64. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 23, 2022 Filed Feb 25, 2022 23:43 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Grant2022 February Restricted Stock Units · Derivative | 53,716 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-013337 · doc4.xml · derivative · entry 1 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,716 Underlying: Common Stock · 53,716 shares Expires not disclosed F1 · derivative.exercise_price: These time-based restricted stock units vest in one-third increments on each of the first, second and third anniversaries of the date of grant. Restricted stock units are settled in shares of the Company's common stock upon vesting. F1 · derivative.exercise_date: These time-based restricted stock units vest in one-third increments on each of the first, second and third anniversaries of the date of grant. Restricted stock units are settled in shares of the Company's common stock upon vesting. F1 · derivative.expiration_date: These time-based restricted stock units vest in one-third increments on each of the first, second and third anniversaries of the date of grant. Restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document |
| December 31, 2021 Filed Jan 4, 2022 23:17 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversion2021 February Restricted Stock Units · Derivative | 23,652 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-001142 · doc4.xml · derivative · entry 7 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,608 Underlying: Common Stock · 23,652 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: As previously reported, on February 24, 2021, the reporting person received a grant of 189,215 time-based restricted stock units that vest and settle in eight equal quarterly installments. The third vesting date occurred on December 31, 2021, resulting in the vesting and settlement of 23,652 shares of common stock, as shown in Table I. The remaining 94,608 restricted stock units are shown in Table II. F4 · derivative.exercise_date: As previously reported, on February 24, 2021, the reporting person received a grant of 189,215 time-based restricted stock units that vest and settle in eight equal quarterly installments. The third vesting date occurred on December 31, 2021, resulting in the vesting and settlement of 23,652 shares of common stock, as shown in Table I. The remaining 94,608 restricted stock units are shown in Table II. F4 · derivative.expiration_date: As previously reported, on February 24, 2021, the reporting person received a grant of 189,215 time-based restricted stock units that vest and settle in eight equal quarterly installments. The third vesting date occurred on December 31, 2021, resulting in the vesting and settlement of 23,652 shares of common stock, as shown in Table I. The remaining 94,608 restricted stock units are shown in Table II. F5 · derivative.underlying: Restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document |
| December 31, 2021 Filed Jan 4, 2022 23:17 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversion2020 February Restricted Stock Units · Derivative | 32,701 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-001142 · doc4.xml · derivative · entry 6 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,806 Underlying: Common Stock · 32,701 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: As previously reported, on February 26, 2020, the reporting person received a grant of 359,713 time-based restricted stock units that vest and settle in eleven equal quarterly installments. The seventh vesting date occurred on December 31, 2021, resulting in the vesting and settlement of 32,701 shares of common stock, as shown in Table I. The remaining 130,806 restricted stock units are shown in Table II. F1 · derivative.exercise_date: As previously reported, on February 26, 2020, the reporting person received a grant of 359,713 time-based restricted stock units that vest and settle in eleven equal quarterly installments. The seventh vesting date occurred on December 31, 2021, resulting in the vesting and settlement of 32,701 shares of common stock, as shown in Table I. The remaining 130,806 restricted stock units are shown in Table II. F1 · derivative.expiration_date: As previously reported, on February 26, 2020, the reporting person received a grant of 359,713 time-based restricted stock units that vest and settle in eleven equal quarterly installments. The seventh vesting date occurred on December 31, 2021, resulting in the vesting and settlement of 32,701 shares of common stock, as shown in Table I. The remaining 130,806 restricted stock units are shown in Table II. F5 · derivative.underlying: Restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document |
| December 31, 2021 Filed Jan 4, 2022 23:17 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Tax withholdingCommon Stock | 7,561 | $81.69 | $617,658.09 |
DisclosureSEC source: 0001209191-22-001142 · doc4.xml · nonDerivative · entry 4 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 586,218 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document |
| December 31, 2021 Filed Jan 4, 2022 23:17 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionCommon Stock | 23,652 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-001142 · doc4.xml · nonDerivative · entry 3 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 593,779 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: As previously reported, on February 24, 2021, the reporting person received a grant of 189,215 time-based restricted stock units that vest and settle in eight equal quarterly installments. The third vesting date occurred on December 31, 2021, resulting in the vesting and settlement of 23,652 shares of common stock, as shown in Table I. The remaining 94,608 restricted stock units are shown in Table II. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 31, 2021 Filed Jan 4, 2022 23:17 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Tax withholdingCommon Stock | 12,868 | $81.69 | $1,051,186.92 |
DisclosureSEC source: 0001209191-22-001142 · doc4.xml · nonDerivative · entry 2 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 570,127 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document |
| December 31, 2021 Filed Jan 4, 2022 23:17 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionCommon Stock | 32,701 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-001142 · doc4.xml · nonDerivative · entry 1 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 582,995 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: As previously reported, on February 26, 2020, the reporting person received a grant of 359,713 time-based restricted stock units that vest and settle in eleven equal quarterly installments. The seventh vesting date occurred on December 31, 2021, resulting in the vesting and settlement of 32,701 shares of common stock, as shown in Table I. The remaining 130,806 restricted stock units are shown in Table II. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 16, 2021 Filed Dec 17, 2021 22:31 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | SaleCommon Stock | 5,799 | $77.86 | $451,510.14 |
DisclosureSEC source: 0001209191-21-070358 · doc4.xml · nonDerivative · entry 1 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 550,294 F1 · price: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $77.75 to $78.24. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| December 10, 2021 Filed Dec 14, 2021 22:43 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | SaleCommon Stock | 6,090 | $76.00 | $462,840.00 |
DisclosureSEC source: 0001209191-21-069551 · doc4.xml · nonDerivative · entry 1 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 556,093 Read SEC document |
| December 08, 2021 Filed Dec 9, 2021 22:04 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | SaleCommon Stock | 65,897 | $76.03 | $5,010,148.91 |
DisclosureSEC source: 0001209191-21-068822 · doc4.xml · nonDerivative · entry 2 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 562,183 F2 · price: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $76.00 to $76.28. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| December 07, 2021 Filed Dec 9, 2021 22:04 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | SaleCommon Stock | 11,308 | $76.01 | $859,521.08 |
DisclosureSEC source: 0001209191-21-068822 · doc4.xml · nonDerivative · entry 1 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 628,080 F1 · price: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $76.00 to $76.08. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| December 03, 2021 Filed Feb 2, 2022 22:02 UTC | IQVIA HOLDINGS INC. IQV · Entity 3058 | GiftCommon Stock | 290 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-22-000006 · wf-form5_164383930182791.xml · nonDerivative · entry 1 Rittenmeyer Ronald A · CIK 0001210018 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,538 Read SEC document |
| November 24, 2021 Filed Nov 26, 2021 18:30 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | SaleCommon Stock | 152 | $79.25 | $12,046.00 |
DisclosureSEC source: 0001209191-21-066913 · doc4.xml · nonDerivative · entry 1 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 639,388 Read SEC document |
| November 23, 2021 Filed Nov 24, 2021 21:50 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | SaleCommon Stock | 21,984 | $79.28 | $1,742,891.52 |
DisclosureSEC source: 0001209191-21-066810 · doc4.xml · nonDerivative · entry 1 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 639,540 F1 · kind: These shares were sold in open market broker transactions. F2 · price: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $79.00 to $79.49. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 22, 2021 Filed Nov 23, 2021 21:50 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | SaleCommon Stock | 29,520 | $79.02 | $2,332,670.40 |
DisclosureSEC source: 0001209191-21-066490 · doc4.xml · nonDerivative · entry 2 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 661,524 F1 · kind: These shares were sold in open market broker transactions. F2 · price: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $79.00 to $79.10. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 19, 2021 Filed Nov 23, 2021 21:50 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | SaleCommon Stock | 95 | $79.00 | $7,505.00 |
DisclosureSEC source: 0001209191-21-066490 · doc4.xml · nonDerivative · entry 1 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 691,044 F1 · kind: These shares were sold in open market broker transactions. Read SEC document |
| November 18, 2021 Filed Nov 19, 2021 22:05 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | SaleCommon Stock | 49,905 | $79.00 | $3,942,495.00 |
DisclosureSEC source: 0001209191-21-065857 · doc4.xml · nonDerivative · entry 1 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 691,139 F1 · kind: These shares were sold in open market broker transactions. F2 · price: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $79.00 to $79.01. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 16, 2021 Filed Nov 17, 2021 23:48 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | SaleCommon Stock | 19,353 | $80.17 | $1,551,530.01 |
DisclosureSEC source: 0001209191-21-065256 · doc4.xml · nonDerivative · entry 2 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 741,044 F1 · kind: These shares were sold in open market broker transactions. F3 · price: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $80.10 to $80.31. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 15, 2021 Filed Nov 17, 2021 23:48 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | SaleCommon Stock | 29,974 | $80.38 | $2,409,310.12 |
DisclosureSEC source: 0001209191-21-065256 · doc4.xml · nonDerivative · entry 1 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 760,397 F1 · kind: These shares were sold in open market broker transactions. F2 · price: The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $80.25 to $80.58. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 21:20 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversion2021 February Restricted Stock Units · Derivative | 23,652 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059068 · doc4.xml · derivative · entry 7 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,260 Underlying: Common Stock · 23,652 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: As previously reported, on February 24, 2021, the reporting person received a grant of 189,215 time-based restricted stock units that vest and settle in eight equal quarterly installments. The third vesting date occurred on September 30, 2021, resulting in the vesting and settlement of 23,652 shares of common stock, as shown in Table I. The remaining 118,260 restricted stock units are shown in Table II. F4 · derivative.exercise_date: As previously reported, on February 24, 2021, the reporting person received a grant of 189,215 time-based restricted stock units that vest and settle in eight equal quarterly installments. The third vesting date occurred on September 30, 2021, resulting in the vesting and settlement of 23,652 shares of common stock, as shown in Table I. The remaining 118,260 restricted stock units are shown in Table II. F4 · derivative.expiration_date: As previously reported, on February 24, 2021, the reporting person received a grant of 189,215 time-based restricted stock units that vest and settle in eight equal quarterly installments. The third vesting date occurred on September 30, 2021, resulting in the vesting and settlement of 23,652 shares of common stock, as shown in Table I. The remaining 118,260 restricted stock units are shown in Table II. F5 · derivative.underlying: Restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 21:20 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversion2020 February Restricted Stock Units · Derivative | 32,701 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059068 · doc4.xml · derivative · entry 6 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,507 Underlying: Common Stock · 32,701 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: As previously reported, on February 26, 2020, the reporting person received a grant of 359,713 time-based restricted stock units that vest and settle in eleven equal quarterly installments. The sixth vesting date occurred on September 30, 2021, resulting in the vesting and settlement of 32,701 shares of common stock, as shown in Table I. The remaining 163,507 restricted stock units are shown in Table II. F1 · derivative.exercise_date: As previously reported, on February 26, 2020, the reporting person received a grant of 359,713 time-based restricted stock units that vest and settle in eleven equal quarterly installments. The sixth vesting date occurred on September 30, 2021, resulting in the vesting and settlement of 32,701 shares of common stock, as shown in Table I. The remaining 163,507 restricted stock units are shown in Table II. F1 · derivative.expiration_date: As previously reported, on February 26, 2020, the reporting person received a grant of 359,713 time-based restricted stock units that vest and settle in eleven equal quarterly installments. The sixth vesting date occurred on September 30, 2021, resulting in the vesting and settlement of 32,701 shares of common stock, as shown in Table I. The remaining 163,507 restricted stock units are shown in Table II. F5 · derivative.underlying: Restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 21:20 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Tax withholdingCommon Stock | 9,308 | $66.44 | $618,423.52 |
DisclosureSEC source: 0001209191-21-059068 · doc4.xml · nonDerivative · entry 4 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 790,371 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 21:20 UTC | TENET HEALTHCARE CORP THC · Entity 2563 | Exercise / conversionCommon Stock | 23,652 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-059068 · doc4.xml · nonDerivative · entry 3 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 799,679 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: As previously reported, on February 24, 2021, the reporting person received a grant of 189,215 time-based restricted stock units that vest and settle in eight equal quarterly installments. The third vesting date occurred on September 30, 2021, resulting in the vesting and settlement of 23,652 shares of common stock, as shown in Table I. The remaining 118,260 restricted stock units are shown in Table II. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.